# Cannabidiol (CBD) in Adults With ASD

> **NCT05015439** · PHASE1 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 40 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05015439
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-20
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05015439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05015439, "Cannabidiol (CBD) in Adults With ASD". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT05015439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*